IRIS
PIERRI, IVANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.412
AS - Asia 317
SA - Sud America 44
NA - Nord America 32
AF - Africa 1
OC - Oceania 1
Totale 9.807
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 9.405
SG - Singapore 147
CN - Cina 75
VN - Vietnam 67
BR - Brasile 27
US - Stati Uniti d'America 22
MX - Messico 9
AR - Argentina 5
EC - Ecuador 5
HK - Hong Kong 5
ID - Indonesia 5
IN - India 3
IQ - Iraq 3
PY - Paraguay 3
DE - Germania 2
IR - Iran 2
PH - Filippine 2
SA - Arabia Saudita 2
VE - Venezuela 2
AZ - Azerbaigian 1
BD - Bangladesh 1
BY - Bielorussia 1
CL - Cile 1
GT - Guatemala 1
JO - Giordania 1
JP - Giappone 1
KE - Kenya 1
KZ - Kazakistan 1
OM - Oman 1
PF - Polinesia Francese 1
PL - Polonia 1
RU - Federazione Russa 1
SE - Svezia 1
UA - Ucraina 1
UY - Uruguay 1
Totale 9.807
Salva come PNG Salva come JPEG
Città #
Genova 6.153
Genoa 1.895
Rapallo 763
Vado Ligure 572
Singapore 68
Ho Chi Minh City 23
Beijing 20
Bordighera 20
Hanoi 19
Ashburn 12
Mexico City 7
Biên Hòa 5
Hong Kong 5
Da Nang 3
Tianjin 3
Torres 3
Bắc Giang 2
Chennai 2
Los Angeles 2
New York 2
Ninh Bình 2
Nuremberg 2
Quito 2
Riyadh 2
São Paulo 2
Amman 1
Araucária 1
Araçatuba 1
Asunción 1
Baghdad 1
Barretos 1
Basra 1
Belo Horizonte 1
Bento Gonçalves 1
Birigui 1
Blumenau 1
Boydton 1
Bắc Ninh 1
Cajazeiras 1
Can Tho 1
Capim Grosso 1
Carira 1
Caruaru 1
Caxias do Sul 1
Chicago 1
Ciputat 1
Ciudad del Este 1
Claypole 1
Cuenca 1
El Tigre 1
Espigão dOeste 1
Guatemala City 1
Guayaquil 1
Haiphong 1
Hangzhou 1
Hurlingham 1
Huế 1
Hưng Yên 1
Hải Dương 1
Iguape 1
Itamari 1
Jiutepec 1
Khulna 1
Kryvyi Rih 1
Ludhiana 1
Manila 1
Mar del Plata 1
Maracaibo 1
Milan 1
Minsk 1
Montevideo 1
Nairobi 1
Nanjing 1
Nanning 1
Nanyang 1
Nasiriyah 1
Olímpia 1
Orem 1
Papeete 1
Pekalongan 1
Phoenix 1
Phủ Lý 1
Porto Alegre 1
Portovelo 1
Providence 1
Pyatigorsk 1
Rio de Janeiro 1
San Juan 1
San Lorenzo 1
San Miguel 1
Santa Bárbara 1
Santa Clara 1
Santo André 1
Seeb 1
Shenzhen 1
Sidoarjo 1
Stockholm 1
São Gonçalo 1
Talagante 1
Thái Bình 1
Totale 9.664
Salva come PNG Salva come JPEG
Nome #
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 229
APO866 activity in hematologic malignancies: a preclinical in vitro study. 215
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112) 204
Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse 190
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 174
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 170
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients 168
Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages 165
Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia. 160
Circadian variations of autologous mixed lymphocyte reactions and endogenous cortisol. 159
Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: role of NKp30 and NKG2D receptors 158
First line therapy with Fludarabine combinations in 42 patients with either post-myelodysplastic syndrome or therapy related acute myeloid leukaemia. 156
Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment 156
T cells from patients with chronic liver diseases: abnormalities in PHA-induced expression of HLA class II antigens and in autologous mixed-lymphocyte reactions. 155
Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemia 153
Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate. 152
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 152
Abnormalities of T cells isolated from mediastinal lymph nodes and peripheral blood of patients with lung carcinoma: deficit in PHA-induced expression of HLA class II antigens and in autologous mixed lymphocyte reactions. 151
Thalidomide in agnogenic and secondary myelofibrosis 149
Analysis of the role of xenogeneic antigens in the proliferation of human T cells stimulated with autologous non-T cells and phytohemagglutinin-activated T cells. 149
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 145
Combination of liposomal Daunorubicin, Fludarabine, and Cytarabine (FLAD) in patients with poor- risk acute leukemia. 143
Evidence for killing of Mesenchymal Stem Cells (MSC) by autologous natural killer lymphocytes. 143
Role of liposomal daunorubicin, fludarabine and cytarabine (FLAD) in the salvage therapy of adult acute lymphoblastic leukemia 138
Molecular analysis of the Imatinib-induced complete cytogenetic response in chronic myelogenous leukemia 137
Therapy of Hodgkin's lymphoma in clinical practice: A retrospective long-term follow-up analysis. 136
Leukocyte-associated Ig-like receptor-1 prevents granulocyte-monocyte colony stimulating factor-dependent proliferation and Akt1/PKB alpha activation in primary acute myeloid leukemia cells 134
HDAC INHIBITORS SYNERGISTICALLY ENHANCE AP0866 ACTIVITY IN HUMAN LEUKEMIA CELLS: EVIDENCE FOR CONVERGING MECHANISMS OF SIRT1 INHIBITION 133
Human T lymphocytes in aging and malignancy: abnormalities in PHA-induced Ia antigen expression and in functional activity in autologous and allogeneic MLR. 133
Kinase domain mutations of BCR-ABL identified at diagnosis before imatinib-based therapy are associated with progression in patients with high Sokal risk chronic phase chronic myeloid leukemia. 132
Acute tuberculous septicemia. 131
An unusual reaction to alpha interferon in a case of non Hodgkin's lymphoma. 129
The addition of radiotherapy to chemotherapy does not improve outcome of early stage Hodgkin's lymphoma patients: a retrospective long-term follow-up analysis of a regional Italian experience. 128
T-lymphocytes phenotype and functions in patients with head and neck cancer. 127
Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients 124
Essential Thrombocythemia: The Dermatologic Point of View 124
Ifosfamide, epirubicin, etoposide (IEV) and autologous peripheral blood progenitor cell transplant: A feasible and effective salvage treatment for lymphoid malignancies 124
[Methods for studying pleiotropic drug resistance (multidrug resistance, MDR)]. 123
Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases 123
WT1 overexpression at diagnosis may predict favorable outcome in patients with de novo non-M3 acute myeloid leukemia. 121
Fludarabine in untreated and previously treated B-CLL patients: a report on efficacy and toxicity. 119
Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients. 117
Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party. 117
Deficiency of the autologous mixed lymphocyte reactions of non-T/T and T/T type in intravenous drug abusers infected by the human immunodeficiency virus (HIV). 117
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study 115
In vivo apoptosis of CD8(+) lymphocytes in acute myeloid leukemia patients: involvement of soluble HLA-I and Fas ligand 114
Detection of platelet-associated antibodies by flow cytometry in hematological autoimmune disorders. 114
Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B 112
New glucocorticoids. Mechanisms of immunological activity at the cellular level and in the clinical setting. 112
Decreased lymphocyte blastogenesis, IL2 production and NK activity following nifedipine administration to healthy humans. 111
Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study. 111
Imatinib treatment induces CD5+ B lymphocytes and IgM natural antibodies with anti-leukemic reactivity in patients with chronic myelogenous leukemia. 111
[Remarks on rupture of the heart in recent myocardial infarct]. 110
Molecular analysis of patients with relapsed or refractory intermediate-high grade non-Hodgkin’s lymphoma with bone marrow infiltration undergoing peripheral blood progenitor cell transplantation 109
Lymphocytapheresis in the treatment of rheumatoid arthritis: clinical and immunological studies. 105
PHA-T cells in systemic lupus erythematosus and in rheumatoid arthritis: abnormalities in HLA class II antigen induction and in autologous mixed lymphocyte reactions. 105
CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells. 105
Weekly standard doses of rh-EPO are highly effective for the treatment of anemic patients with low-intermediate 1 risk myelodysplastic syndromes. 104
Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates pro-apoptotic signals in chronic lymphocytic leukemia B cells 103
Plasmaexchange plus immunoglobulins for treatment of hypergammaglobulinaemic patients with AIDS and AIDS-related complex (ARC). 102
Human autologous mixed lymphocyte reactions (a review). 100
Role of normal adherent cells in the regulation of the autologous mixed lymphocyte reactions in humans. 100
[Plasmacytoid lymphoma of the lung. Presentation of a case and review of the literature]. 99
High efficacy of fludarabine-containing therapy (FLAG-FLANG) in poor risk acute myeloid leukemia. 97
In vitro enhancement of the proliferative response of human T cells to autologous non-T cells by hydralazine. 95
Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia. 94
Seventeen years of experience with ATRA-based therapy for acute promyelocytic leukaemia: long-term follow-up of patients treated at S. Martino Hospital, Genoa 91
Cost of de novo acute myeloid leukemia induction therapy in adults: analysis of EORTC-GIMEMA AML10 and FLANG regimens. 91
CTLA-4 expressed by chemoresistant, as well as untreated, myeloid leukaemia cells cdan be targeted with ligands to induce apoptosis 91
Expression of HLA-class II antigens and proliferative capacity in autologous mixed lymphocyte reactions of human T lymphocytes exposed in vitro to alpha-endorphin. 90
GM-CSF, ARA-C, VP-16 and idarubicin (GM-IVA), a short, and effective induction treatment for de novo AML, suitable for the elderly. 86
[Granulomatous giant-cell endometritis due to talc]. 86
Detection of minimal residual disease in B-lymphoproliferative disorders: a three step SSCP-PCR method. 82
The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase. 82
Lymphoplasmacytic lymphoma/immunocytoma: towards a disease-targeted treatment? 76
Decreased sensitivity of T lymphocytes to normal adherent suppressor cells in patients with head and neck cancer. 75
GM-IVA, a short induction course for de novo acute myeloid leukemia, suitable for the elderly. 75
Immunocompetence in lung cancer patients: analysis of serological and cellular parameters. 71
Thiol containing antioxidant drugs and the human immune system. 71
Totale 9.858
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.022
article - articoli 29.022
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.044
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021321 0 0 0 0 0 48 12 45 45 65 55 51
2021/2022943 27 73 48 111 30 60 77 206 34 88 36 153
2022/2023939 109 72 16 103 166 168 5 67 155 1 71 6
2023/2024485 27 62 8 51 45 111 24 23 20 7 30 77
2024/20251.344 19 106 41 78 210 151 111 206 40 69 152 161
2025/2026886 272 47 66 149 301 51 0 0 0 0 0 0
Totale 9.858